154 related articles for article (PubMed ID: 11053977)
1. ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy.
Wapstra FH; Navis GJ; van Goor H; van den Born J; Berden JH; de Jong PE; de Zeeuw D
Exp Nephrol; 2001; 9(1):21-7. PubMed ID: 11053977
[TBL] [Abstract][Full Text] [Related]
2. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
Wapstra FH; Van Goor H; Navis G; De Jong PE; De Zeeuw D
Clin Sci (Lond); 1996 May; 90(5):393-401. PubMed ID: 8665777
[TBL] [Abstract][Full Text] [Related]
3. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
Bos H; Henning RH; De Boer E; Tiebosch AT; De Jong PE; De Zeeuw D; Navis G
Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
[TBL] [Abstract][Full Text] [Related]
4. Glomerular basement membrane anionic sites in adriamycin nephropathy: effect of saline loading and nitric oxide modulation.
Hertzan-Levy S; Fish R; Skutelsky E; Wollman Y; Chernichovsky T; Polak-Charcon S; Schwartz D; Blum M; Cabili S; Iaina A
Nephron; 2000 Apr; 84(4):354-61. PubMed ID: 10754413
[TBL] [Abstract][Full Text] [Related]
5. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Weening JJ; Berden JH
Kidney Int; 1993 Feb; 43(2):454-63. PubMed ID: 8441243
[TBL] [Abstract][Full Text] [Related]
6. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
Shinosaki T; Takagawa I; Sunagawa N; Yonetani Y; Kurihara H
Jpn J Pharmacol; 1997 Apr; 73(4):337-45. PubMed ID: 9165371
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats.
Macconi D; Ghilardi M; Bonassi ME; Mohamed EI; Abbate M; Colombi F; Remuzzi G; Remuzzi A
J Am Soc Nephrol; 2000 Mar; 11(3):477-489. PubMed ID: 10703671
[TBL] [Abstract][Full Text] [Related]
8. Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Wapstra FH; Navis G; DE Jong PE; DE Zeeuw D
J Am Soc Nephrol; 2000 Mar; 11(3):490-496. PubMed ID: 10703672
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
[TBL] [Abstract][Full Text] [Related]
10. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats.
Rada JA; Carlson EC
Anat Rec; 1991 Sep; 231(1):35-47. PubMed ID: 1750710
[TBL] [Abstract][Full Text] [Related]
11. Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.
Wapstra FH; van Goor H; de Jong PE; Navis G; de Zeeuw D
J Pharmacol Toxicol Methods; 1999; 41(2-3):69-73. PubMed ID: 10598677
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
13. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH
Kidney Int; 1992 Jan; 41(1):115-23. PubMed ID: 1593846
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
Haas M; de Boer E; de Jong PE; Moolenaar F; Meijer DK; de Zeeuw D
Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
[TBL] [Abstract][Full Text] [Related]
16. Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable.
de Boer E; Navis G; Wapstra FH; de Jong PE; de Zeeuw D
Kidney Int Suppl; 1999 Jul; 71():S42-6. PubMed ID: 10412735
[TBL] [Abstract][Full Text] [Related]
17. Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats.
Heeringa P; Van den Born J; Brouwer E; Dolman KM; Klok PA; Huitema MG; Limburg PC; Bakker MA; Berden JH; Daha MR; Kallenberg CG
Clin Exp Immunol; 1996 Aug; 105(2):321-9. PubMed ID: 8706341
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.
Laverman GD; Van Goor H; Henning RH; De Jong PE; De Zeeuw D; Navis G
Kidney Int; 2003 Jan; 63(1):64-71. PubMed ID: 12472769
[TBL] [Abstract][Full Text] [Related]
19. Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage.
Kramer AB; Laverman GD; van Goor H; Navis G
J Pathol; 2003 Sep; 201(1):160-7. PubMed ID: 12950029
[TBL] [Abstract][Full Text] [Related]
20. Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
Bos H; Laverman GD; Henning RH; Tiebosch AT; de Jong PE; de Zeeuw D; Navis G
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):106-12. PubMed ID: 12806593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
